Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent

The present invention is directed to the use of a type II anti-CD20 antibody for the manufacture of a medicament for the treatment of cancer, especially of CD20 expressing cancers in combination with an anti-Bcl-2 active agent.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHRISTIAN KLEIN, THOMAS FRIESS, PAMELA BRAEMER, PABLO UMANA
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	CHRISTIAN KLEIN THOMAS FRIESS PAMELA BRAEMER PABLO UMANA
description	The present invention is directed to the use of a type II anti-CD20 antibody for the manufacture of a medicament for the treatment of cancer, especially of CD20 expressing cancers in combination with an anti-Bcl-2 active agent.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2008314068A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2008314068A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2008314068A13</originalsourceid><addsrcrecordid>eNrjZAh2zs9NysxLLMnMz1MoyUgtSiyoVMhPU0hUKKksSFXw9FRIzCvJ1HV2MTIAs5LyUyoVyjNLMoA8iJRTco6ukUJicklmWapCYnpqXgkPA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYl3DDUyMLAwNjQxMLNwNDQmThUAG0M2_w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent</title><source>esp@cenet</source><creator>CHRISTIAN KLEIN ; THOMAS FRIESS ; PAMELA BRAEMER ; PABLO UMANA</creator><creatorcontrib>CHRISTIAN KLEIN ; THOMAS FRIESS ; PAMELA BRAEMER ; PABLO UMANA</creatorcontrib><description>The present invention is directed to the use of a type II anti-CD20 antibody for the manufacture of a medicament for the treatment of cancer, especially of CD20 expressing cancers in combination with an anti-Bcl-2 active agent.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090423&DB=EPODOC&CC=AU&NR=2008314068A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090423&DB=EPODOC&CC=AU&NR=2008314068A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHRISTIAN KLEIN</creatorcontrib><creatorcontrib>THOMAS FRIESS</creatorcontrib><creatorcontrib>PAMELA BRAEMER</creatorcontrib><creatorcontrib>PABLO UMANA</creatorcontrib><title>Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent</title><description>The present invention is directed to the use of a type II anti-CD20 antibody for the manufacture of a medicament for the treatment of cancer, especially of CD20 expressing cancers in combination with an anti-Bcl-2 active agent.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAh2zs9NysxLLMnMz1MoyUgtSiyoVMhPU0hUKKksSFXw9FRIzCvJ1HV2MTIAs5LyUyoVyjNLMoA8iJRTco6ukUJicklmWapCYnpqXgkPA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYl3DDUyMLAwNjQxMLNwNDQmThUAG0M2_w</recordid><startdate>20090423</startdate><enddate>20090423</enddate><creator>CHRISTIAN KLEIN</creator><creator>THOMAS FRIESS</creator><creator>PAMELA BRAEMER</creator><creator>PABLO UMANA</creator><scope>EVB</scope></search><sort><creationdate>20090423</creationdate><title>Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent</title><author>CHRISTIAN KLEIN ; THOMAS FRIESS ; PAMELA BRAEMER ; PABLO UMANA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2008314068A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHRISTIAN KLEIN</creatorcontrib><creatorcontrib>THOMAS FRIESS</creatorcontrib><creatorcontrib>PAMELA BRAEMER</creatorcontrib><creatorcontrib>PABLO UMANA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHRISTIAN KLEIN</au><au>THOMAS FRIESS</au><au>PAMELA BRAEMER</au><au>PABLO UMANA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent</title><date>2009-04-23</date><risdate>2009</risdate><abstract>The present invention is directed to the use of a type II anti-CD20 antibody for the manufacture of a medicament for the treatment of cancer, especially of CD20 expressing cancers in combination with an anti-Bcl-2 active agent.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_AU2008314068A1
source	esp@cenet
subjects	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A23%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHRISTIAN%20KLEIN&rft.date=2009-04-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2008314068A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true